Published: November 17, 2022
The Miami CTSI joined researchers and leaders of hubs across the national consortium at the 2022 In-Person CTSA Program Annual Meeting held in Washington, D.C., earlier this month.
Three from the Miami CTSI’s Executive Leadership Team were in attendance — Co-Director and MPI Olveen Carrasquillo, M.D, M.P.H., Co-Director and MPI Erin Kobetz, Ph.D., M.P.H., and Executive Director of CTSI Business Operations Daru Ransford.
Presentations and posters covered a range of topics under the overarching theme of “Achieving Health Equity through the Science of Translation.” The Miami CTSI spotlighted two of its pilot projects at the poster session.
Jacquelyn Moffitt, a University of Miami graduate student in Department of Psychology, presented a poster on the “Objective Behavioral Measurement to Address Health Disparities in Autism Spectrum Disorder Diagnosis,” based on her work with collaborators Amy Ahn and Miami CTSI pilot awardees Daniel Messinger, Ph.D., and Lynn Perry, Ph.D.
The second project presented looked at the effectiveness of an entertainment education intervention for decreasing internalized HIV-stigma and increasing HIV status disclosure intentions and medical adherence intentions among Black women living with HIV in the Southern U.S. The research is a collaboration between CTSI pilot awardee Nick Carcioppolo, Ph.D., JoNell Efantis Potter, Ph.D., APRN, FAAN, and researchers at Florida A&M University and MD Anderson Cancer Center.
Keynote addresses were given by Dr. Robert Califf, Commissioner of the Food and Drug Administration, as well as by newly appointed Director of NCATS, Dr. Joni Rutter, Dr. Michael Kurilla, of NCATS, and Dr. Laura James, of University of Arkansas for Medical Sciences, Chair of the National CTSA Steering Committee.